CVS Health Corp (CVS · NYSE)
CVS · MARKET VIEW
Market view · as of Sep 28, 2026
Price (last ~year)
CVS Health shares rose 4.8% to $89.13, reclaiming the 200-day moving average after eight straight losing sessions, though the stock remains down 14.4% over three months and 18.9% below its 52-week high. The rebound followed a second-quarter beat — adjusted EPS of $2.58 versus $1.87 estimated, the fourth consecutive earnings beat — on revenue of $106.10B, up 7.1% year over year. Operating results have recovered sharply from the September 2025 quarter's operating loss of $3.21B, with the last two quarters each posting roughly $4.7B in operating income and EBITDA near $5.9B. The company generated $5.65B in free cash flow in the quarter against total debt of $76.31B (4.6x EBITDA), and the stock trades at 23.52x earnings with an analyst target of $116.28.
Valuation
- Market cap
- $113.99B
- P/E
- 23.52
- PEG
- 0.211
- P/B
- 1.449
- P/S
- 0.276
- EV/EBITDA
- 13.26
- Beta
- 0.58
- Analyst target
- $116.28
Quality & returns
- Gross margin
- 13.6%
- Operating margin
- 3.9%
- Profit margin
- 1.2%
- ROE
- 6.2%
- ROA
- 3.0%
Price movement
- Last
- $89.13
- 1-month
- -4.1%
- 3-month
- -14.4%
- RSI (14)
- 28
- vs SMA200
- +2.8%
- 52-wk position
- 49.1% -18.9% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $106.10B | $4.70B | $3.00B | $5.86B |
| 2026-03-31 | $100.43B | $4.68B | $2.94B | $5.83B |
| 2025-12-31 | $105.69B | $2.11B | $2.94B | $3.29B |
| 2025-09-30 | $102.87B | $-3.21B | $-3.98B | $-1.56B |
Recent news
- Somewhat-Bullish The first mRNA flu vaccine is now available for older adults. Here’s what to know · 2026-09-27
- Neutral Polaris Pays a 5.15% Yield. Should Income Investors Trust It More Than Hasbro? · 2026-09-27
- Somewhat-Bullish Is CVS Health (CVS) Cheap As Renewables And Cancer Care Expansion Lift Optimism? · 2026-09-26
- Neutral CVS Health stock at USD 89.13 on September 25, 2026 · 2026-09-26
- Somewhat-Bullish Microsoft Corporation stock Analysis: Bullish Momentum Near Record Highs · 2026-09-26
- Neutral CVS Health Corporation stock Analysis: Mixed Signals After 4.8% Surge · 2026-09-26
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)